LBCA Executive Director, Laurie Hutcheson interviewed our newest Scientific Advisory Board (SAB) member, Dr. Mothaffar Rimawi, to talk about his work in breast cancer research. Dr. Rimawi is a board-certified medical oncologist and translational clinical researcher, the Associate Director for Clinical Affairs and Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center at the Baylor College of Medicine. His research focuses on translation of preclinical discoveries by conducting biologically rational, biospecimen-intense targeted therapy clinical trials with associated tissue-based biomarker studies. He discovered and developed several biomarkers of response and resistance to therapy in breast cancer making him a leader in precision oncology approaches. Hear Dr. Rimawi’s passionate dedication to expanding research into lobular breast cancer and why he so highly values working with patient advocates. 

To learn more about LBCA’s Scientific Advisory Board, click here.